Pro-Dex (NASDAQ:PDEX) Shares Cross Above 200 Day Moving Average of $17.27
Pro-Dex (NASDAQ:PDEX) Shares Cross Above 200 Day Moving Average of $17.27
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $17.27 and traded as high as $17.99. Pro-Dex shares last traded at $17.48, with a volume of 2,397 shares.
在周三的交易中,Pro-Dex,Inc.(纳斯达克代码:PDEX-GET Rating)的股价突破了200日移动均线切入位17.27美元,最高交易价格为17.99美元。Pro-Dex的股票最新报17.48美元,成交量为2,397股。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
Separately, StockNews.com began coverage on Pro-Dex in a report on Wednesday, December 7th. They set a "hold" rating for the company.
另外,StockNews.com在12月7日星期三的一份报告中开始报道Pro-Dex。他们为该公司设定了“持有”评级。
Pro-Dex Stock Performance
Pro-Dex股票表现
The firm has a market capitalization of $62.58 million, a price-to-earnings ratio of 16.81 and a beta of 0.91. The company has a fifty day moving average of $18.11 and a two-hundred day moving average of $17.27. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.39 and a current ratio of 2.73.
该公司市值为6258万美元,市盈率为16.81倍,贝塔系数为0.91。该公司的50日移动均线切入位在18.11美元,200日移动均线切入位在17.27美元。该公司的负债权益比率为0.41,速动比率为1.39,流动比率为2.73。
Institutional Trading of Pro-Dex
Pro-Dex的机构交易
Pro-Dex Company Profile
Pro-Dex公司简介
(Get Rating)
(获取评级)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Pro-Dex公司为世界各地的医疗器械原始设备制造商设计、开发、制造和销售动力手术器械。该公司提供可高压灭菌、电池供电和电动的多功能外科驱动程序和剃须刀,主要用于整形外科、胸部和颅颌面部市场。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- 3 Mid-Caps That Could Double in 2023
- Mullen Automotive Shares Jump After Signing New Partner
- REV Group Leads Specialty Vehicle Manufacturers Higher
- NVIDIA vs AMD: Which is better for 2023?
- Can FDA Approval Bolster DexCom, Inc.?
- 免费获取StockNews.com Pro-Dex上的研究报告(PDEX)
- 2023年中型股可能翻一番
- 马伦汽车签署新合作伙伴后股价上涨
- REV集团引领专用车制造商走高
- NVIDIA VS AMD:2023年哪一种更好?
- FDA的批准能支持DexCom,Inc.吗?
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
接受Pro-Dex Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Pro-Dex和相关公司的最新新闻和分析师评级的每日简要摘要。